Verastem Oncology
VSTM
#7331
Rank
โ‚ฌ0.39 B
Marketcap
5,31ย โ‚ฌ
Share price
2.46%
Change (1 day)
-4.79%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: โ‚ฌ0.39 Billion

As of February 2026 Verastem Oncology has a market cap of โ‚ฌ0.39 Billion. This makes Verastem Oncology the world's 7331th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.39 B-22.68%
2025โ‚ฌ0.51 B225.69%
2024โ‚ฌ0.15 B-14.72%
2023โ‚ฌ0.18 B136.02%
2022โ‚ฌ78.83 M-76.1%
2021โ‚ฌ0.32 B12.17%
2020โ‚ฌ0.29 B206.78%
2019โ‚ฌ95.83 M-55.79%
2018โ‚ฌ0.21 B67.64%
2017โ‚ฌ0.12 B228.28%
2016โ‚ฌ39.38 M-37.32%
2015โ‚ฌ62.84 M-69.32%
2014โ‚ฌ0.20 B-2.02%
2013โ‚ฌ0.20 B54.5%
2012โ‚ฌ0.13 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Verastem Oncology was reported to be:

โ‚ฌ0.34 Billion
by Nasdaq info icon info icon
โ‚ฌ0.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ128.66 B 32,099.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ19.06 B 4,671.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ90.01 B 22,426.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
โ‚ฌ9.56 M-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA